Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Kristine Broglio, Lale Kostakoglu, Carol Ward, Federico Mattiello, Denis Sahin, Tina Nielsen, Anna McGlothlin, Corrine F. Elliott, Thomas Witzig, Laurie H. Sehn, Marek Trnĕný, Umberto Vitolo, Maurizio Martelli, Margaret Foster, Barbara Wendelberger, Grzegorz Nowakowski & Donald A. Berry. (2022) PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial design. Leukemia & Lymphoma 63:12, pages 2816-2831.
Read now
Read now
Karen J. Mylam, Tarec C. El-Galaly, Martin Hutchings, Peter Brown, Bodil Himmelstrup, Oke Gerke, Dorte Gillstrøm, Ida B. Sillesen, Lars Munksgaard, Bjarne B. Pedersen, Ilse Christiansen, Paw Jensen, Anne L. Nielsen & Lars M. Pedersen. (2014) Prognostic impact of clinician-based interpretation of 18F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma. Leukemia & Lymphoma 55:7, pages 1563-1569.
Read now
Read now
Vaishalee P. Kenkre, Sarah Horowitz, Andrew S. Artz, Chuanhong Liao, Kenneth S. Cohen, Lucy A. Godley, Justin P. Kline, Sonali M. Smith, Wendy Stock & Koen van Besien. (2011) T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse. Leukemia & Lymphoma 52:2, pages 214-222.
Read now
Read now
Peter Martin. (2010) When 18-fluorodeoxyglucose-positron emission tomography is indeterminate, the International Prognostic Index is the answer. Leukemia & Lymphoma 51:4, pages 569-570.
Read now
Read now
Articles from other publishers (13)
Sujeet Kumar, Anshul Gupta, Manish Ora, Khaliqur Rahman, Sanjeev, Reena Choudhary & Soniya Nityanand. (2021) Prognostic Role of Interim 18-Fluorodeoxyglucose-PET in Diffuse Large B Cell Lymphoma: Experience from a Tertiary Care Centre in North India. Indian Journal of Hematology and Blood Transfusion 38:2, pages 211-222.
Crossref
Crossref
Theodoros P. Vassilakopoulos, Athanassios Liaskas, Alexia Piperidou, Maria Ioakim & Vassilios Prassopoulos. 2022. Artificial Intelligence in PET/CT Oncologic Imaging. Artificial Intelligence in PET/CT Oncologic Imaging
109
151
.
Ryogo Minamimoto, Luis Fayad, Julie Vose, Jane Meza, Ranjana Advani, Jordan Hankins, Felix Mottaghy, Homer Macapinlac, Alexander Heinzel, Malik E. Juweid & Andrew Quon. (2021) 18F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter study. European Journal of Nuclear Medicine and Molecular Imaging 48:9, pages 2883-2893.
Crossref
Crossref
Renata Nyilas, Bence Farkas, Reka Rahel Bicsko, Ferenc Magyari, Laszlo Imre Pinczes, Arpad Illes & Lajos Gergely. (2019) Interim PET/CT in diffuse large B-cell lymphoma may facilitate identification of good-prognosis patients among IPI-stratified patients. International Journal of Hematology 110:3, pages 331-339.
Crossref
Crossref
Lale Kostakoglu & Grzegorz S. Nowakowski. (2019) End-of-Treatment PET/Computed Tomography Response in Diffuse Large B-Cell Lymphoma. PET Clinics 14:3, pages 307-315.
Crossref
Crossref
Theodoros P. Vassilakopoulos & Vassilios K. Prassopoulos. 2018. Imaging in Clinical Oncology. Imaging in Clinical Oncology
619
647
.
Hugo J.A. Adams & Thomas C. Kwee. (2016) Proportion of false-positive lesions at interim and end-of-treatment FDG-PET in lymphoma as determined by histology: Systematic review and meta-analysis. European Journal of Radiology 85:11, pages 1963-1970.
Crossref
Crossref
Theodoros P. Vassilakopoulos, Vassilios K. Prassopoulos, Phoivi Rondogianni, Sofia N. Chatziioannou, Vasileios I. Telonis & Effimia P. Vrakidou. 2016. PET/CT in Lymphomas. PET/CT in Lymphomas
111
171
.
Christina Kalpadakis, Gerassimos A. Pangalis, Dimitrios T. Kechagias, Xanthi Yiakoumis & Fani J. Vlachou. 2016. PET/CT in Lymphomas. PET/CT in Lymphomas
229
243
.
Theodoros P. Vassilakopoulos, Vassilios Prassopoulos, Phoivi Rondogianni, Sofia Chatziioannou, Kostas Konstantopoulos & Maria K. Angelopoulou. (2015) Role of FDG-PET/CT in staging and first-line treatment of Hodgkin and aggressive B-cell lymphomas. memo - Magazine of European Medical Oncology 8:2, pages 105-114.
Crossref
Crossref
Theodoros P. Vassilakopoulos & Vassilios K. Prassopoulos. 2014. Imaging in Clinical Oncology. Imaging in Clinical Oncology
249
265
.
Ali Gholamrezanezhad, Alin Chirindel & Rathan Subramaniam. 2012. PET-CT and PET-MRI in Oncology. PET-CT and PET-MRI in Oncology
279
322
.
Bhanu Vakkalanka & Brian K. Link. (2011) Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma. Advances in Hematology 2011, pages 1-7.
Crossref
Crossref